维普期刊资源整合服务平台（V6.5）

107篇 您的检索式：作者名="Giezen"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	显示文摘	John W Geus Joep C van Giezen	1999	Catalysis Today1999，47，：	2
2	Complemention of the inability of Lactococcus strains to utilize D-xylose catabolismencoding genes of Lactococcus pentosus 显示文摘	Posno M Heuvelmans PT van Giezen MJ	1991	Appl Environ Microbiol1991，57，6：	1
3	Ticagrelor inhibits adenosine uptakein vitro and enhances adenosine-mediated hyperemia responses in a caninemodel显示文摘	Van Giezen J J J Sidaway J Glaves P	2012	Journal of cardiovascular pharmacology and therapeutics2012，17，2：	1
4	Ticagrelor inhibits adenosine uptake in vitro and enhances adenosine- mediated hyperemia responses in a canine model显示文摘	van GIEZEN J J SIDAWAY J GLAVES P	2011	J Cardiovasc Pharmacol Ther2011，17，2：	1
5	Perinatalmicronutrient supplements ameliorate hypertension and pro-teinuria in adult fawn-hooded hypertensive rats 显示文摘	Koeners MP Braam B van der Giezen DM	2010	Am J Hy-pertens2010，23，7：	1
6	Ticagrelor inhibits adenosine uptake in vitro and enhances adenosine-mediated hyperemia responses in a canine model 显示文摘	van Giezen J J Sidaway J Glares P	2012	J Cardiovasc Pharmacol Ther2012，17，2：	1
7	Comparison of ticagrelor and thienopyridine P2Y12 binding characteristics and antithrombotic and bleeding effects in rat and dog models of thrombosis/hemostasis显示文摘	Giezen JV Bemtsson P Zachrisson H	2009	Thrombosis Research2009，124，5：	1
8	Ticagrelor inhibits adenosine uptake in vitro and enhances adenosine-mediated hyperemia responses in a canine model显示文摘	van Giezen JJ Sidaway J Glaves P	2012	J Cardiovasc Pharmacol Ther2012，17，2：	1
9	The Fab-fragment of a PAI-1 inhibiting antibody reduces thrombus size and restores blood flow in a rat model of arterial thrombosis显示文摘	Van Giezen J J Wahlund G Nerme A T	1997	Thromb Haemost1997，77，5：	1
10	Ticagrelor binds to human P2Y (12)independently from ADP but antagonizes ADP- induced receptor signaling and platelet aggregation显示文摘	Van Giezen JJ Nilsson L Berntsson P	2009	J Thromb Haemost2009，7，9：	1
11	Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist显示文摘	Husted S Giezen J J	2009	Cardiovasc Ther2009，27，4：	1
12	Complementation of the inability of Lactococcus strains to utilize D-xylose catabolism-encoding genes of Lactococcus pentosus显示文摘	POSNO M HEUVELMANS P T van GIEZEN M J	1991	Appl Enyiron Microbiol1991，57，：	1
13	Ticagrelor:the first reversibly binding oral P2Y12 receptor antagonist 显示文摘	Husted S van Giezen JJ	2009	Cardiovasc Ther2009，27，4：	1
14	Ti- cagrelor binds to human P2Y (12) independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation显示文摘	VAN Giezen J J Nilsson L Berntsson P	2009	J Thromb Haemost2009，7，9：	1
15	Ticagrelor inhibits adenosine uptake in vitro and enhances adenosine mediated hyperemia responses in a canine model 显示文摘	Van Giezen JJ Sidaway J Glaves P	2012	J Cardiovasc Pharmacol Ther2012，17，2：	1
16	Comparison of ticagrelor and thienopyridine P2Y(12) binding characteristics and antithrombotic and bleeding effects in rat and dog models of thrombo- sis/hemostasis显示文摘	van Giezen JJ Berntsson P Zachrisson H	2009	Thromb Res2009，124，5：	1
17	Preelinical and clini- cal studies with selective reversible direct P2Y12 antagonists显示文摘	van Giezen JJ Humphries RG	2005	Semin Thromb Hemost2005，31，2：	1
18	Ti- cagrelor binds to human P2Y12 independently from ADP but an- tagonizes ADP-induced receptor signaling and platelet aggregation 显示文摘	VAN GIEZEN JJJ NILSSON L BERNTSSON P	2009	J Thrombos Haemostas2009，7，9：	1
19	Safety- related regulatory actions for biologicals approved in the United States and the European Union显示文摘	Giezen T J Mantel-Teeuwisse A K Straus S M	2008	JAMA2008，300，16：	1
20	Comparison of ticagrelor and thienopyridine P2Y12 binding characteristics and antithrombotic and bleeding effects in rat and dog models of thrombosis/hem 显示文摘	Van Giezen J J J Bemtsson P Zachrisson H	2009	Thrombosis Research2009，124，：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示